Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML)

Summary

The study investigates if CPX-351 will be a) more effective than the standard intensive salvage AML treatment and b) more tolerable than the standard intensive salvage treatment regimens. The study compares the investigational product CPX-351 vs the standard intensive salvage treatment for first relapse AML patients.

Timeline

Start

2009-02

Primary completion

2011-12

Completion

2012-01

Drugs

Indications